Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Endometrium > FUR1021b
  • Cores:
    102
    CASES:
    102
    Core Diameter(mm):
    1
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    13
    Tissue Array Type:
    FFPE
    Species:
    Human
FUR1021b
$255.00
Add To Collect

Description: Endometrium cancer with endometrium tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores, replacing EM1021a

Details: Endometrium adenocarcinomawith endometrium tissue microarray, containing 96 cases endometrioid adenocarcinoma, 1 adenosquamous carcinoma, 5 normal tissue, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Normal(*)
  • NAT(*)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IC)
  • Malignant(IIA)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(III)
TISSUE ARRAYS
FUR1021b
1
2
3
4
5
6
7
8
9
10
11
12
13
A
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
B
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
C
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
D
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
E
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
F
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
G
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
H
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
FUR1021b
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 68 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A2
2 62 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A3
3 46 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A4
4 35 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A5
5 65 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A6
6 51 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A7
7 53 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A8
8 55 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A9
9 76 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
A10
10 50 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
A11
11 40 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A12
12 62 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A13
13 55 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
B1
14 42 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
B2
15 60 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B3
16 41 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
B4
17 51 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B5
18 45 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
B6
19 52 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B7
20 58 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B8
21 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
B9
22 66 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
B10
23 51 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B11
24 50 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B12
25 36 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B13
26 58 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
C1
27 56 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
C2
28 61 F Uterus Endometrioid adenocarcinoma 1--2 T1cN0M0 IC Malignant
C3
29 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C4
30 64 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
C5
31 57 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
C6
32 63 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
C7
33 57 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
C8
34 62 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
C9
35 68 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
C10
36 56 F Uterus Endometrioid adenocarcinoma 1 T2aN0M0 IIA Malignant
C11
37 52 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant
C12
38 56 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C13
39 53 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
D1
40 56 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant
D2
41 72 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D3
42 60 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
D4
43 58 F Uterus Endometrioid adenocarcinoma * T1bN0M0 IB Malignant
D5
44 70 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant
D6
45 55 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
D7
46 63 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
D8
47 58 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D9
48 52 F Uterus Endometrioid adenocarcinoma 2 T3aN0M0 IIIA Malignant
D10
49 74 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
D11
50 54 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
D12
51 74 F Uterus Endometrioid adenocarcinoma * T1bN0M0 IB Malignant
D13
52 58 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E1
53 50 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E2
54 60 F Uterus Endometrioid adenocarcinoma (sparse) * T1bN0M0 IB Malignant
E3
55 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E4
56 64 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
E5
57 49 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E6
58 71 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E7
59 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E8
60 66 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E9
61 60 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E10
62 40 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E11
63 53 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant
E12
64 49 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E13
65 56 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F1
66 60 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
F2
67 56 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F3
68 62 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F4
69 67 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
F5
70 57 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F6
71 64 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F7
72 65 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F8
73 46 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F9
74 64 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F10
75 53 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
F11
76 54 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
F12
77 53 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
F13
78 74 F Uterus Endometrioid adenocarcinoma 2--3 T2N0M0 II Malignant
G1
79 58 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G2
80 53 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G3
81 56 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
G4
82 47 F Uterus Endometrioid adenocarcinoma * T1cN0M0 IC Malignant
G5
83 55 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G6
84 55 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
G7
85 68 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant
G8
86 60 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
G9
87 48 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant
G10
88 61 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G11
89 78 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant
G12
90 48 F Uterus Endometrioid adenocarcinoma 3 T3N0M0 III Malignant
G13
91 44 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
H1
92 57 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
H2
93 33 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
H3
94 58 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
H4
95 62 F Uterus Adenosquamous carcinoma * T1cN0M0 IC Malignant
H5
96 64 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 2 T1bN0M0 IB Malignant
H6
97 61 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 2 T1bN0M0 IB Malignant
H7
98 21 F Uterus Endometrium tissue * * * Normal
H8
99 41 F Uterus Endometrium tissue * * * Normal
H9
100 18 F Uterus Endometrium tissue * * * Normal
H10
101 21 F Uterus Endometrium tissue (sparse) * * * Normal
H11
102 31 F Uterus Adjacent normal endometrium tissue * * * NAT
Find overlapping cases with this tissue array:
  • FUR1021b
    File Format: .xlsx
    Release Date: 2025-01-17 16:01:02
    Download
2.870038s